Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9607
-0.0174 (-1.78%)
At close: Jun 12, 2026, 4:00 PM EDT
0.9812
+0.0205 (2.13%)
After-hours: Jun 12, 2026, 6:58 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $183.27 million as of June 12, 2026. Its market cap has increased by 18.67% in one year.
Market Cap
183.27M
Enterprise Value
180.71M
1-Year Change
18.67%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $183.27M, a decrease of -64.35%. That is a compound annual growth rate of -19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 183.27M | 28.26% |
| Dec 31, 2025 | 142.90M | 214.80% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 241.27M |
| TriSalus Life Sciences | 231.54M |
| Quantum-Si incorporated | 206.15M |
| Apyx Medical | 196.39M |
| RxSight | 194.98M |
| InfuSystem Holdings | 184.46M |
| Inogen | 173.28M |
| Quanterix | 146.03M |